Stock analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Calithera Biosciences stock opened at $0.01 on Friday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.
Calithera Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- Why Are Stock Sectors Important to Successful Investing?
- Western Digital: Is the Storage Sector Set for a Rebound?
- How to Profit From Value Investing
- Wingstop Stock Jumps on Q1 Beat, Expansion Outlook
- How Can Investors Benefit From After-Hours Trading
- Why Energy Stocks Like Exxon and Hess Are Back in Focus
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
